Total Payments
$9,690
2024 Payments
$296.80
Companies
45
Transactions
701
Medicare Patients
2,630
Medicare Billing
$294,591
Payment Breakdown by Category
Food & Beverage$9,539 (98.4%)
Research$125.00 (1.3%)
Education$26.41 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,539 | 695 | 98.4% |
| Unspecified | $125.00 | 1 | 1.3% |
| Education | $26.41 | 5 | 0.3% |
Payments by Type
General
$9,565
700 transactions
Research
$125.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,578 | 167 | $0 (2024) |
| PFIZER INC. | $945.59 | 87 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $926.61 | 84 | $0 (2022) |
| Novo Nordisk Inc | $790.75 | 57 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $731.33 | 52 | $0 (2023) |
| ABBVIE INC. | $526.58 | 42 | $0 (2022) |
| Merck Sharp & Dohme LLC | $472.66 | 36 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $406.72 | 27 | $0 (2024) |
| Indivior Inc. | $389.85 | 20 | $0 (2019) |
| Amarin Pharma Inc. | $220.09 | 15 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $296.80 | 18 | AstraZeneca Pharmaceuticals LP ($200.51) |
| 2023 | $509.92 | 34 | AstraZeneca Pharmaceuticals LP ($190.26) |
| 2022 | $870.20 | 63 | AstraZeneca Pharmaceuticals LP ($180.30) |
| 2021 | $1,606 | 115 | AbbVie Inc. ($268.03) |
| 2020 | $1,470 | 101 | AstraZeneca Pharmaceuticals LP ($460.33) |
| 2019 | $1,475 | 108 | AstraZeneca Pharmaceuticals LP ($491.72) |
| 2018 | $1,691 | 138 | AstraZeneca Pharmaceuticals LP ($491.25) |
| 2017 | $1,771 | 124 | AstraZeneca Pharmaceuticals LP ($353.26) |
All Payment Transactions
701 individual payment records from CMS Open Payments — Page 4 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/14/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.28 | General |
| Category: NEUROSCIENCE | ||||||
| 06/10/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: NEUROSCIENCE | ||||||
| 06/07/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/25/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: Diabetes | ||||||
| 05/25/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $9.00 | General |
| Category: Gastroenterology | ||||||
| 05/20/2022 | Scilex Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $13.43 | General |
| 05/18/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: PRIMARY CARE | ||||||
| 05/16/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/13/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.90 | General |
| Category: NEUROSCIENCE | ||||||
| 04/28/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Gastroenterology | ||||||
| 04/28/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: NEUROSCIENCE | ||||||
| 04/25/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.55 | General |
| Category: RESPIRATORY | ||||||
| 04/20/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: DIABETES | ||||||
| 04/20/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $7.77 | General |
| Category: Gastroenterology | ||||||
| 04/13/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.49 | General |
| Category: NEUROSCIENCE | ||||||
| 04/08/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: NEUROSCIENCE | ||||||
| 04/07/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Cardiovascular | ||||||
| 04/06/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: PRIMARY CARE | ||||||
| 04/05/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/30/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Gastroenterology | ||||||
| 03/28/2022 | VBI Vaccines (Delaware) Inc. | PreHevbrio (Drug) | Food and Beverage | Cash or cash equivalent | $14.79 | General |
| Category: VACCINE | ||||||
| 03/17/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Gastroenterology | ||||||
| 03/15/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/14/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/12/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: NEUROSCIENCE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Quantitative Testing of Prescriber Knowledge, Attitudes and Behavior about SUBOXONE buprenorphine and naloxone Sublingual Film CIII Safety and Use Information | Indivior Inc. | $125.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 854 | 1,443 | $137,471 | $85,310 |
| 2022 | 12 | 651 | 1,098 | $116,525 | $72,547 |
| 2021 | 10 | 551 | 1,016 | $112,930 | $71,651 |
| 2020 | 12 | 574 | 1,171 | $129,825 | $65,084 |
Total Patients
2,630
Total Services
4,728
Medicare Billing
$294,591
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 142 | 499 | $74,900 | $46,122 | 61.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 115 | 227 | $29,380 | $14,002 | 47.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 85 | 85 | $12,725 | $11,658 | 91.6% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 147 | 147 | $3,675 | $2,949 | 80.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 38 | 38 | $3,020 | $2,648 | 87.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 123 | 123 | $3,075 | $2,485 | 80.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $2,200 | $1,425 | 64.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 44 | 45 | $1,125 | $1,078 | 95.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 87 | $2,191 | $1,054 | 48.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 84 | 124 | $2,480 | $1,042 | 42.0% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 20 | 21 | $945.00 | $544.80 | 57.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 22 | 23 | $1,495 | $250.60 | 16.8% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 12 | 13 | $260.00 | $51.22 | 19.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 123 | 420 | $63,000 | $39,613 | 62.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 114 | 211 | $27,250 | $13,246 | 48.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 83 | 83 | $12,475 | $11,954 | 95.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 41 | 43 | $3,115 | $2,937 | 94.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $2,300 | $1,419 | 61.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 49 | 52 | $1,300 | $1,276 | 98.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 52 | 52 | $1,300 | $1,053 | 81.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 68 | 106 | $2,120 | $307.71 | 14.5% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 12 | 12 | $300.00 | $251.04 | 83.7% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 63 | 65 | $1,625 | $229.49 | 14.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 19 | 20 | $1,300 | $177.99 | 13.7% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2022 | 15 | 22 | $440.00 | $83.22 | 18.9% |
About Dr. Charles Peeples, MD
Dr. Charles Peeples, MD is a Internal Medicine healthcare provider based in Oakhurst, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1477558518.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Peeples, MD has received a total of $9,690 in payments from pharmaceutical and medical device companies, with $296.80 received in 2024. These payments were reported across 701 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($9,539).
As a Medicare-enrolled provider, Peeples has provided services to 2,630 Medicare beneficiaries, totaling 4,728 services with total Medicare billing of $294,591. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Oakhurst, NJ
- Active Since 06/16/2005
- Last Updated 10/22/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1477558518
Products in Payments
- FARXIGA (Drug) $1,984
- XARELTO (Drug) $702.09
- XIFAXAN (Drug) $690.98
- CHANTIX (Drug) $470.25
- JARDIANCE (Drug) $349.94
- Ozempic (Drug) $347.57
- JANUVIA (Drug) $326.71
- Vascepa (Drug) $220.09
- INVOKANA (Drug) $218.50
- Victoza (Drug) $200.54
- SYMBICORT (Drug) $185.35
- VRAYLAR (Drug) $175.63
- SUBLOCADE (Drug) $173.86
- COLOGUARD DNA CAPTURE REAGENTS (Device) $154.31
- LYRICA (Drug) $145.62
- SUBOXONE (Drug) $142.40
- UBRELVY (Drug) $141.89
- SOLIQUA (Drug) $123.03
- BELSOMRA (Drug) $109.95
- MOVANTIK (Drug) $108.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Oakhurst
Dr. John Ciciarelli, Md, MD
Internal Medicine — Payments: $42,609
Internal Medicine $42,609
Dr. Aleksey Kretov, Md, MD
Internal Medicine — Payments: $18,333
Internal Medicine $18,333
Dr. Richard Mojares, M.d, M.D
Internal Medicine — Payments: $6,285
Internal Medicine $6,285
Dr. Dharmesh Kaswala, Md, MD
Internal Medicine — Payments: $6,113
Internal Medicine $6,113
Reza Akhtar, Md, MD
Internal Medicine — Payments: $6,097
Internal Medicine $6,097
Dr. Richard Meltzer, M.d, M.D
Internal Medicine — Payments: $4,298
Internal Medicine $4,298